SCHEMBL3482795

SCHEMBL3482795

CC(=O)OC[C@H]1O[C@@H](c2cc(I)c([C@@H]3O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]3OC(C)=O)cc2I)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 1/20 0.64
▸ PTPN1 P18031 1/20 0.58
▸ NR3C1 P04150 1/20 0.51
▸ FYN P06241 1/20 0.51
▸ ADRA2A P08913 1/20 0.51
▸ ADORA3 P0DMS8 1/20 0.51
▸ ADRA2B P18089 1/20 0.51
▸ DRD4 P21917 1/20 0.51
▸ DRD3 P35462 1/20 0.51
▸ CYP2D6 P10635 1/20 0.49
▸ THRB P10828 1/20 0.49
▸ HSD17B10 Q99714 1/20 0.49
▸ CA12 O43570 13/20 0.48
▸ CA1 P00915 13/20 0.48
▸ CA2 P00918 12/20 0.48
▸ CA9 Q16790 9/20 0.48
▸ CA4 P22748 8/20 0.48
▸ CA5A P35218 8/20 0.48
▸ CA7 P43166 8/20 0.48
▸ CA5B Q9Y2D0 8/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15135039 0.92 TSHR (0.56) TSHRPTPN1NR3C1FYNADRA2A
SCHEMBL15134997 0.85 TSHR (0.49) TSHRPTPN1NR3C1FYNADRA2A
SCHEMBL3482641 0.81 TSHR (0.79) TSHRPTPN1NR3C1FYNADRA2A
SCHEMBL9007978 0.80 TSHR (0.69) TSHRPTPN1NR3C1FYNADRA2A
SCHEMBL9007982 0.80 TSHR (0.69) TSHRPTPN1NR3C1FYNADRA2A
SCHEMBL4368202 0.79 TSHR (0.64) TSHRPTPN1NR3C1FYNADRA2A
SCHEMBL12762931 0.78 TSHR (1.00) TSHRPTPN1NR3C1FYNADRA2A
SCHEMBL9008057 0.78 TSHR (0.60) TSHRPTPN1NR3C1FYNADRA2A
SCHEMBL8587623 0.78 TSHR (0.57) TSHRPTPN1NR3C1FYNADRA2A
SCHEMBL9008049 0.78 TSHR (0.60) TSHRPTPN1NR3C1FYNADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2121647-B1 ORGANIC THIN FILM TRANSISTORS COMPRISING THIENYL OLIGOMERS AND THEIR USE AS GASEOUS PHASE SENSORS UNIV BARI (IT) 2014-09-24 — — EP disclosed
US-8461354-B2 Organic thin film transistors comprising thienyl oligomers and their use as gaseous phase sensors UNIVERSITA' DEGLI STUDI DI BARI (IT) 2013-06-11 — — US disclosed
US-20100140597-A1 Organic thin film transistors comprising thienyl oligomers and their use as gaseous phase sensors UNIVERSITA' DEGLI STUDI DI BARI (IT) 2010-06-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100140597-A1 Organic thin film transistors comprising thienyl oligomers and their use as gaseous phase sensors TPR, TTR, TRPA1 TSHR 1882/4885PTPN1 2641/4885NR3C1 1235/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback